Kevin P. Starr - 15 Jun 2023 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Reporting relationship: Director
Issuer ticker: SAGE
Reported as of: 15 Jun 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jun 2023, 16:05:30 UTC
Prior SEC filing: 17 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Kevin P. Starr

Key filing fact

Kevin P. Starr filed Form 4 for Sage Therapeutics, Inc. (SAGE) on 16 Jun 2023.

Key facts

This page summarizes Kevin P. Starr's Form 4 filing for Sage Therapeutics, Inc. (SAGE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 16 Jun 2023, 16:05.

Change

Previous filing in this sequence was filed on 17 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SAGE transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +10,000
Change %
Price: $0.000000
Shares after: 10,000
Date: 15 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $56.10
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan in accordance with the terms of the Amended and Restated Non-Employee Director Compensation Policy. The option will vest in full upon the earlier to occur of June 15, 2024 or the day immediately prior to the 2024 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date.